RECOMBINANT INTERFERON ALFA-2C VERSUS POLYCHEMOTHERAPY (VMCP) FOR TREATMENT OF MULTIPLE-MYELOMA - A PROSPECTIVE RANDOMIZED TRIAL

被引：48

作者：

LUDWIG, H ^{[1
]}

CORTELEZZI, A ^{[1
]}

SCHEITHAUER, W ^{[1
]}

VANCAMP, BGK ^{[1
]}

KUZMITS, R ^{[1
]}

FILLET, G ^{[1
]}

PEETERMANS, M ^{[1
]}

POLLI, E ^{[1
]}

FLENER, R ^{[1
]}

机构：

[1] VIENNA UNIV,DEPT MED 2,A-1090 VIENNA,AUSTRIA

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1986年 / 22卷 / 09期

关键词：

D O I：

10.1016/0277-5379(86)90015-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1111 / 1116

页数：6

相关论文

共 18 条

[1] AAPRO MS, 1983, CANCER CHEMOTH PHARM, V10, P161
[2] AHRE A, 1984, CANCER TREAT REP, V68, P1331
[3] ALEXANIAN R, 1982, CLIN HAEMATOLOGY, P211
[4] INTERFERON THERAPY IN MULTIPLE-MYELOMA - FAILURE OF HUMAN FIBROBLAST INTERFERON ADMINISTRATION TO AFFECT THE COURSE OF LIGHT CHAIN DISEASE
BILLIAU, A
BLOEMMEN, J
BOGAERTS, M
CLAEYS, H
VANDAMME, J
DELEY, M
DESOMER, P
DROCHMANS, A
HEREMANS, H
KRIEL, A
SCHETZ, J
TRICOT, G
VERMYLEN, C
VERWILGHEN, R
WAER, M
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (08): : 875 - 882
[5] CLARK RH, 1984, J BIOL RESP MODIF, V3, P613
[6] COOPER MR, 1985, P AM SOC CLIN ONCOL, V4, P216
[7] PHASE-II STUDY OF RECOMBINANT ALPHA-2 INTERFERON IN RESISTANT MULTIPLE-MYELOMA
COSTANZI, JJ
COOPER, MR
SCARFFE, JH
OZER, H
GRUBBS, SS
FERRARESI, RW
POLLARD, RB
SPIEGEL, RJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (05) : 654 - 659
[8] EINHORN S, 1978, HUMAN INTERFERON PRO, P159
[9] CLINICAL AND IMMUNOLOGICAL STUDIES OF HUMAN FIBROBLAST INTERFERON
EZAKI, K
OGAWA, M
OKABE, K
ABE, K
INOUE, K
HORIKOSHI, N
INAGAKI, J
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 8 (01) : 47 - 55
[10] LEUKOCYTE INTERFERON-INDUCED TUMOR-REGRESSION IN HUMAN METASTATIC BREAST-CANCER, MULTIPLE-MYELOMA, AND MALIGNANT-LYMPHOMA
GUTTERMAN, JU
BLUMENSCHEIN, GR
ALEXANIAN, R
YAP, HY
BUZDAR, AU
CABANILLAS, F
HORTOBAGYI, GN
HERSH, EM
RASMUSSEN, SL
HARMON, M
KRAMER, M
PESTKA, S
[J]. ANNALS OF INTERNAL MEDICINE, 1980, 93 (03) : 399 - 406